Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11M Buy
275,000
+175,000
+175% +$8.28M ﹤0.01% 1413
2025
Q4
$4.5M Hold
100,000
﹤0.01% 2090
2025
Q3
$4.47M Buy
+100,000
New +$4.79M ﹤0.01% 2048
2021
Q2
Sell
-49,133
Closed -$2.54M 6351
2021
Q1
$2.54M Buy
49,133
+47,153
+2,381% +$2.59M ﹤0.01% 2332
2020
Q4
$111K Sell
1,980
-14,712
-88% -$785K ﹤0.01% 5461
2020
Q3
$925K Buy
+16,692
New +$866K ﹤0.01% 3341
2018
Q4
Sell
-47,153
Closed -$1.89M 7803
2018
Q3
$1.89M Sell
47,153
-94,305
-67% -$3.77M ﹤0.01% 2790
2018
Q2
$5.42M Sell
141,458
-188,611
-57% -$6.94M 0.01% 1756
2018
Q1
$11.3M Buy
330,069
+47,152
+17% +$1.66M 0.01% 1147
2017
Q4
$9.28M Buy
+282,917
New +$9.75M 0.01% 1348

Other funds holding QGEN

Citigroup's QGEN Position: Q1 2026 in Review

Citigroup reduced its Qiagen (QGEN) stake by 1.8% in Q1 2026, selling an estimated $1.22M and leaving 1,385,111 shares worth $55.5M. The position accounts for 0.02% of the portfolio, ranked #601.

Citigroup first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $437M in Q2 2020. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Citigroup held 1,385,111 shares of Qiagen worth $55.5M as of Q1 2026.
  • Citigroup sold 25,825 Qiagen shares in Q1 2026, an estimated $1.22M.
  • Qiagen made up 0.02% of Citigroup's portfolio in Q1 2026, its #601 holding.
  • Citigroup first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
  • Citigroup's Qiagen position peaked at $437M in Q2 2020.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.